Position in ALEC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,915,368
+$1,678,026 QoQ
Shares Held
2,286,218
+10.2% QoQ
Ownership
2.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. ALEC ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in ALEC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,915,368 | 2,286,218 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,237,342 | 2,075,220 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $5,509,323 | 1,861,258 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,774,895 | 1,982,068 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,413,380 | 1,962,098 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,617,931 | 1,914,250 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $8,872,369 | 1,903,942 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,970,355 | 1,755,585 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $9,486,135 | 1,575,770 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $11,026,652 | 1,381,786 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,443,938 | 1,303,077 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,751,229 | 1,289,722 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,543,901 | 1,218,724 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,004,827 | 1,192,289 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $10,581,274 | 1,118,528 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,115,619 | 1,094,057 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $15,337,118 | 1,076,289 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $21,925,364 | 1,061,761 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $22,814,705 | 999,768 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $20,426,043 | 980,607 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $17,098,759 | 848,995 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $11,761,275 | 777,348 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,786,271 | 739,086 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $15,931,311 | 651,854 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $13,344,469 | 553,024 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||